A Multi-Centered, Randomized, Two-Arm, Open Label Study to Evaluate Safety, Tolerability and Efficacy of Induction Treatment With Mitoxantrone Preceding Treatment With Glatiramer Acetate (Copaxone) Versus Chronic Treatment With Glatiramer Acetate Alone in Relapsing Forms of Multiple Sclerosis (MS)
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Glatiramer acetate (Primary) ; Mitoxantrone (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2010 Results presented at the 62nd Annual Meeting of the American Academy of Neurology.